18 F-FDG-PET, and MRI performed. Our main findings were: 1) Different Alzheimer's disease predilection areas showed increased 18 F-Flut retention at different CSF A␤ 42 concentrations (posterior regions were involved at higher concentrations). 2) There were strong negative correlations between regional cortical 18 F-Flut and 18 F-FDG uptake. 3) Increased 18 F-Flut uptake were observed in multiple subcortical regions in amyloid positive subjects, including investigated reference regions. However, WM hyperintensity 18 F-Flut standardized uptake value ratios (SUVr) were not significantly different, thus we cannot definitely conclude that the higher uptake in 18 F-Flut(+) is due to amyloid deposition. In conclusion, our findings support clinical use of CSF A␤ 42 , putatively relate decreasing CSF A␤ 42 concentrations to a sequence of regional amyloid deposition, and associate amyloid pathology to cortical hypometabolism. However, we cannot conclude that 18 F-Flut-PET is a suitable marker for WM pathology due to high aberrant WM uptake.
INTRODUCTION
Aggregation and deposition of amyloid-␤ peptides (A␤) into plaques is considered a key event in the evolution of Alzheimer's disease (AD) [1] . There are two types of amyloid biomarkers: assays to mea-plaques [7] . Other possible explanations are inconsistencies in amyloid PET rating, incorrect handling or between-laboratory and batch-to-batch CSF assay variability, a known issue for these analyses [8] . Hence standardization is important for correct detection of incipient AD. We have insufficient knowledge about at which CSF A␤ 42 concentrations amyloid PET becomes abnormal, and in which areas this happens first. CSF analyses are likely more available, and such knowledge may improve the diagnostic accuracy of CSF A␤ 42 also to predict regional deposition at different CSF A␤ 42 concentrations.
[ 11 C] Pittsburgh compound B ( 11 C-PiB) [9] is widely investigated, but 18 F-labelled amyloid radiotracers (with increased availability due to longer half-life) have more recently been developed. Herein, we investigate [ 18 F]-Flutemetamol ( 18 F-Flut) [10] (a structural analogue to 11 C-PiB). 11 C-PiB and 18 FFlut are comparable with respect to cortical retention, but 18 F-Flut typically presents with higher white matter (WM) uptake [11] . Possible explanations for the higher WM 18 F-Flut uptake include non-specific uptake related to lipophilicity [12] in the high lipid content WM, and aberrant binding to the ␤-sheet structured myelin basic protein [13] . 18 F-Flut clearance is also slower in WM compared to grey matter (GM) [14] . 18 F-Flut WM retention may pose challenges due to partial volume effects (PVE) (i.e., spill-over from areas of high uptake to adjacent areas of low uptake) [15] . It is not clear to which extent WM 18 F-Flut uptake depends on pathology (e.g., WM amyloid load or pathology of the capillary bed) or is aberrant and unspecific, warranting further investigation of 18 FFlut for use in WM.
Applying PVE correction (PVC) enhances quantitative accuracy of 18 F-Flut PET [15] , and may also avoid bias in WM analyses. PVC may optimize PET images for studies of WM function and pathology, as we recently demonstrated with [ 18 F]-fluorodeoxyglucose PET (FDG-PET) [16] (and also with diffusion tensor imaging [17] ).
White matter hyperintensities of presumed vascular origin (WMHs) [18] (as visualized on T2-weighted MRI images) are thought to reflect underlying small-vessel cerebrovascular disease (CVD) [18] . There is strong evidence for an association between CVD and AD [19] , but it is not certain whether there is a pathomechanistic interaction, or whether CVD is an independent process with manifestations like hippocampal atrophy [20] and synergistic effects on the clinical symptoms of AD.
In both AD and CVD [21] , there are microvascular alterations with capillary dysfunction, and the neurovascular unit is affected, impairing the blood-brain barrier and clearance of soluble substances [22, 23] , and even amyloid deposits may be located at the outer basement membrane (cerebral amyloid angiopathy (CAA) type 1 [24] ).
Establishing the potential contribution of amyloid pathology to vascular alterations (or vice versa) seen in AD may be of diagnostic, preventive and therapeutic value. To date, a handful studies have applied 11 C-PiB to analyses of WM, showing reduced retention in WMHs compared to normal-appearing WM (NAWM) [25] [26] [27] . 11 C-PiB is also shown to label vascular amyloid depositions [28, 29] as well as cortical deposits, a feature that may also be attributable to 18 F-Flut given their structural similarities. WM 18 FFlut binding has been characterized [13] , but to the best of our knowledge use of 18 F-Flut in WMH has not been examined.
The objectives of the current study were therefore 1) to compare CSF A␤ 42 and 18 F-Flut uptake to evaluate the different A␤ concentrations at which regional 18 F-Flut uptake becomes abnormal, 2) to investigate associations between cortical 18 F-Flut and 18 F-FDG uptake, and 3) to investigate the potential use of 18 FFlut in analyses of WM pathology. For comparative purposes, we analyzed 18 F-Flut uptake in different reference regions, regions not prone to plaque deposition, and also compared subcortical retention in subjects classified as 18 F-Flut positive and 18 F-Flut negative to investigate potential contribution of amyloid dysmetabolism to WM pathology in AD.
MATERIAL AND METHODS

Subjects
Forty-eight subjects were included from a longitudinal cohort followed at a university hospital from 2013 to 2016 (Fig. 1) , of whom 29 are female. Inclusion criteria were age 40-80, complaints of cognitive decline relative to the previously normal state and Scandinavian first language. Exclusion criteria were established dementia, previous brain injury (including recognized stroke), neurodevelopmental disorder, and established serious psychiatric or somatic disorder, as well as drug use (including chemotherapy), which could significantly influence the cognitive function. All enrolled subjects had a standardized clinical assessment including physical examination, magnetic resonance imaging (MRI), lumbar puncture Inclusions and exclusions in the cohort. Two subjects of <55 years of age were excluded to limit between-group age differences. PET, positron emission tomography; WMH, white matter hyperintensities; 18 F-Flut, 18 F-Flutemetamol.
(n = 42), 18 F-Flut PET (n = 48), and 18 F-FDG PET (n = 34). All of the abovementioned procedures were performed within 3.5 months at the given assessment. The current data were collected either from time of inclusion (baseline) (n = 28), or at second assessment two years after inclusion (n = 20), given that they had not converted to dementia. The investigators were blinded to the subjects' identities.
Physicians trained in diagnosing cognitive disorders established the final diagnoses in consensus conferences. Almdahl et al. have described the diagnostic criteria, including the cognitive test battery, in detail [30] . Mild cognitive impairment (MCI, n = 15) was defined according to the core criteria in the recommendations from the National Institute on Aging/Alzheimer's Association (NIA/AA) [31] . Subjective cognitive decline (SCD) (n = 29) was defined based on the recommendations by the Subjective Cognitive Decline Initiative Working Group [32] . All forty-eight subjects had preserved functions of daily living, with Clinical Dementia Rating score ≤0.5 [33] , i.e., not demented. Two subjects were classified as preclinical AD stage 2 according to recommendations from the NIA/AA [34] , based on one positive amyloid marker (positive 18 F-Flut PET) and evidence of neuronal injury (pathological CSF total and/or phosphorylated tau). Two additional subjects were classified as preclinical AD stage 3 according the NIA/AA criteria, based on positive 18 F-Flut PET, evidence of neurodegeneration (pathological CSF tau), and with subtle cognitive decline.
One subject was excluded from the current study due to an incomplete PET scan (one frame only). One subject was excluded due to total WMH volume <350 mm 3 , as we considered this as a minimum volume for robust analyses. Between-group age differences were limited by excluding subjects aged <50 years (n = 2). The remaining forty-four subjects were dichotomized according to cortical 18 F-Flut PET uptake and classified as positive ( 18 F-Flut(+)) or negative ( 18 F-Flut(-)), as determined by visual interpretation by trained readers blinded to any clinical information and CSF A␤ 42 . The images were compared to a normal brain database supplied by the manufacturer of the tracer (CortexID, GE Healthcare, Chicago, IL, USA) and the subjects were classified as 18 18 F-Flut scan sessions, a bolus injection of 185 MBq (5 mCi) was followed by rest before positioning the subject head-first supine in the scanner. Prior to PET acquisition, a low-dose CT scan for attenuation correction was acquired. PET scanning in 3D-mode started 45 minutes after injection of 18 F-FDG and 90 minutes after 18 F-Flut. PET data were acquired for 10 minutes for 18 F-FDG (six frames) and for 20 minutes (four frames of five minutes) for 18 F-Flut. Acquired data were corrected for random events, dead time, attenuation, scatter, and decay. PET volumes were reconstructed using an iterative algorithm (VUE Point FX SharpIR with six iterations, 24 subsets for 18 F-FDG, four iterations, 16 subsets for 18 F-Flut) and a post-reconstruction 3D Gaussian filter of 3 mm fullwidth half maximum was applied. The PET detector was cylindrical, 700 mm in the xy-plane and 153 mm in the z-plane, and there were 47 slices for both 18 
Image processing
For the quantitative assessment, motion correction of the 18 F-Flut PET was performed using frameby-frame rigid registration, then the frames were summed to a single time-frame image and rigidly registered to the anatomical MRI volume using a 6-parameter rigid registration as implemented in the Spatial Parametrical Mapping (SPM 12, Wellcome Trust Centre for Neuroimaging, UCL, UK) toolbox.
Due to the relatively poor scanner resolution, PET images are susceptible to partial volume effects. Because these spill-over effects may impact the quantification of the regional uptake [15] , we recently developed an algorithm to correct for partial volume effects [35] . This is a voxel-based algorithm that relies on MRI based segmentation of anatomical regions and accurate measurements of the effective point spread function of the PET imaging process. The PVC algorithm was applied to the 18 F-Flutand 18 F-FDG PET images using an estimated PSF of 5.34 × 4.79 × 5.55 mm [36] . 18 F-Flut-and 18 F-FDG PET images and structural images were further co-registered to high-resolution 3D T1-weighted MRI scans for WMH segmentation and measurements. Registrations were manually inspected for accuracy.
An in-house developed object-based supervised machine-learning algorithm was used for automated segmentation and quantification of WMHs based on FLAIR image intensity and masks of tissue types [37] . For all segmentations, a single investigator (LFK) performed manual inspection of accuracy and edited when necessary. The reconstruction and segmentation of WM was performed with the FreeSurfer image analysis suite version 5.3.0 (http://surfer.nmr.mgh.harvard.edu/). This includes segmentation of the subcortical white-matter and deep grey-matter volumetric structures, and parcellation of the cortical surface. NAWM was defined by subtracting WMH from the total WM. Analyses and calculations were performed using The Oxford Centre for Functional MRI of the Brain (FMRIB) Software Library (FSL) version 5.0 [38, 39] . 18 FFlut and 18 F-FDG standardized uptake value ratios (SUVr) were obtained by normalization to the cerebellar cortex. Prior to normalization, the cerebellar mask was eroded by 1 mm to avoid partial volume effects, inaccurate segmentation or co-registration. 18 F-Flut and 18 F-FDG uptake were analyzed in five pre-selected cortical regions of interest (ROIs), as defined by Desikan et al. [40] , known to hold substantial amyloid plaques in AD: the precuneus and posterior cingulate combined, anterior cingulate, prefrontal, inferior parietal, and lateral temporal cortex [41] . These are also the regions used for clinical evaluation of 18 F-Flut status according to the manufacturer's guidelines [42] . We chose to only include early predilection sites for amyloid deposition in this subanalysis. We further calculated a composite SUVr by averaging the uptake in the above-mentioned regions. For comparative purposes, the 18 F-Flut uptake was also analyzed in the hippocampus, parahippocampal gyrus, and entorhinal cortex. The 18 F-Flut and 18 F-FDG uptake for each region were averaged across the hemispheres, and the cerebellar cortex was used as the reference region.
Cerebrospinal fluid analyses
Lumbar puncture was performed consecutively after inclusion, between 8 a.m. and noon, at the L3/L4, L4/L5, or L5/S1 interspace. CSF was examined for the traditional CSF biomarkers A␤ 42 , T-tau, and P-tau and quantified with commercially available ELISAs (Fujirebio Europe, Gent, Belgium). The analyses were carried out in accordance with the manufacturers' instructions at the national reference laboratory for these tests at the Department of Interdisciplinary Laboratory Medicine and Medical Biochemistry, Akershus University Hospital. The laboratory recommends the following cut-off values for abnormality (modified from Sjögren et al. [43] ); t-tau >300 pg/ml for age <50 years, >450 pg/ml for age 50-69 years, and >500 pg/ml for age ≥70 years, p-tau ≥ 80 pg/ml and A␤ 42 < 550 pg/ml. The national reference laboratory is part of the European multicenter project "Biomarkers for Alzheimer's disease and Parkinson's disease" (BIOMARKAPD), funded by EU Joint Programme-Neurodegenerative Disease Research (JPND), for standardization of analytical methods and laboratory procedures to increase its accuracy with regard to CSF biomarkers of neurodegenerative diseases.
Statistical analyses
Demographic and clinical features were assessed using chi-square tests for categorical data and independent-samples T-test or Mann-Whitney U test for continuous data. The WMH volume was logarithmically transformed prior to group-difference analyses. 42 To determine the CSF A␤ 42 concentrations associated with abnormal 18 F-Flut uptake, slope and intercept values from regression equations representing associations between regional 18 F-Flut and CSF A␤ 42 were used. Abnormal 18 F-Flut SUVr was defined as SUVr > 1.46, as previously published [44] . Receiver operating characteristic (ROC) curves were used to determine the sensitivity and specificity of the different CSF A␤ 42 concentrations (as compared to 18 F-Flut). All SUVr were PVE corrected. Linear regression was used to correct for age and sex, and the residuals were used for correlation analyses.
Regional cortical 18 F-Flut and CSF Aβ
Associations between cortical 18 F-Flut and 18 
F-FDG uptake
Spearman correlations were computed for assessment of associations between regional 18 F-Flut SUVr and CSF A␤ 42 , as well as correlations between cortical 18 F-Flut and 18 F-FDG SUVr. All SUVr were PVE corrected.
Regional 18 F-Flutemetamol retention and relevance to white matter pathology
We investigated 18 F-Flut uptake prior to normalization to reference regions, exploring a putative pathology-specific increased retention in regions commonly used as reference for intensity normalization. Such standardized uptake values (SUV) were also analyzed in cerebral WM, WMHs, and NAWM for comparative purposes. SUV was calculated by dividing the mean regional radioactivity by the injected dose and body weight. SUVr were analyzed for cortical regions. Hippocampal, parahippocampal and entorhinal SUVr were analyzed for comparative purposes. Ratios were calculated by dividing the uptake for each region in 18 F-Flut(+) by 18 F-Flut(-), and Independent Samples T-tests and Mann-Whitney U tests were conducted to test for significance. For SUVr age and total WMH volume were included as covariates.
To analyze the potential use of 18 F-Flut as a marker of WM pathology, 18 F-Flut uptake in WMH and NAWM were determined prior to and after normalization to reference region, and group differences (i.e., 18 F-Flut(+) versus 18 F-Flut(-)) were assessed with Independent-Samples T-Tests. 18 F-Flut WMHs retention was logarithmically transformed prior to the analyses. Age and total WMH volume were included as covariates for analyses of SUVr, and the ensuing residuals were normally distributed. Retention in WMHs and NAWM were compared using PairedSamples T test. For assessment of the WMHs binding of 18 F-Flut, we investigated associations between the 18 F-FDG SUVr and 18 F-Flut SUVr in WMHs using Spearman correlation. Linear regression was used to correct for age and total WMH volume, and the resulting residuals were used for the correlation analyses. In addition, Spearman correlations were used to determine associations between 18 F-Flut SUVr in WMHs and cortex, as well as associations between 18 F-FDG SUVr in WMHs and cortical 18 FFlut SUVr.
All tests were performed with significance level set at p < 0.05. Statistical analyses were performed with SPSS version 23 (SPSS Inc., Chicago, IL, USA).
RESULTS
Demographic and clinical data are listed in Table 1 . There were no significant group differences in sex, age, WMH volume, or Mini-Mental State Examination score. By design, 18 F-Flut (+) presented with significantly lower CSF A␤ 42 and larger cortical SUVr of 18 F-Flut when compared to 18 F-Flut (-). 42 We compared regional cortical SUVr of 18 F-Flut and CSF A␤ 42 . Figure 2 summarizes the results, and illustrates the CSF A␤ 42 concentration (vertical dotted line) at which abnormal 18 F-Flut SUVr (>1.46, horizontal dotted line) would be identified for each AD-specific region (also the composite region). Corresponding CSF A␤ 42 levels ranged from 645 pg/ml in the anterior cingulate cortex to 762 pg/ml in the inferior parietal lobe, yielding sensitivities 87-93% and specificities 85-93% (Fig. 3 ). There were strong negative correlations between CSF A␤ 42 and 18 F-Flut SUVr for all regions; precuneus and posterior cingulate cortex (r = -0.85, p < 0.001), anterior cingulate cortex (r = -0.76, p < 0.001), prefrontal lobe (r = -0.68, p < 0.001), inferior parietal lobe (r = -0.79, p < 0.001) and lateral temporal lobe (r = -0.72, p < 0.001).
Regional cortical 18 F-Flut and CSF Aβ
Associations between cortical 18 F-Flut and 18 F-FDG uptake
There were strong negative Spearman correlations between regional cortical 18 F-Flut and 18 F-FDG uptake in 18 Regional 18 F-Flutemetamol retention and relevance to white matter pathology 18 F-Flut SUVs (i.e., prior to intensity normalization against a reference region) were analyzed in several regions, in both PVE corrected and uncorrected images, primarily to investigate the validity of typical reference regions used for further analyses. We found numerically higher retention in all regions in subjects classified as 18 F-Flut(+) compared to 18 F-Flut(-). Based on the comparison of the SUV values between possible reference regions, we used the cerebellum cortex as reference region to calculate SUVr values. Before PVE correction, significant differences were also observed in subcortical WM and NAWM. Cortical ROIs were analyzed using SUVr. As expected, highly significant differences were observed in cortical regions (p < 0.001) when comparing 18 F-Flut(+) and 18 F-Flut(-). Results are summarized in Table 2 .
White matter hyperintensities. Before and after PVE corrections 18 F-Flut SUVs were higher in WMHs in 18 F-Flut(+) compared to 18 F-Flut(-) ( Table 2 ). No significant difference (p = 0.112) was observed in NAWM when comparing 18 F- (Table 3) . 18 F-FDG uptake in WMHs and cortical 18 F-Flut SUVr in the AD-predilection cortical regions were negatively correlated. No significant correlations were found between 18 F-Flut uptake in WMHs and cortex.
DISCUSSION
In this study, we combined three AD biomarkers, CSF A␤ 42 , 18 F-Flut -and 18 F-FDG PET, finding that CSF A␤ 42 concentrations associated with abnormal 18 F-Flut uptake differ between predilection areas for AD pathology, posterior areas demonstrating a pathological high retention at higher CSF A␤ 42 levels . . We showed strong negative correlations between cortical 18 F-Flut and 18 F-FDG uptake. To our knowledge, we are the first to evaluate the use of 18 F-Flut in WMHs. We found generally higher 18 F-Flut retention throughout the brain in 18 F-Flut(+) subjects prior to normalization, including subcortical WM. We found significantly higher WMH 18 F-Flut uptake in 18 F-Flut(+) as compared to 18 FFlut(-) without normalizing to a reference region, but after normalization the differences were noticeably reduced. Significance shown in bold. SUVr, standardized uptake value ratios; FDG, fluorodeoxyglucose; WMHs, white matter hyperintensities.
Brain amyloid pathology is a core diagnostic clinical criterion of AD, as evidenced by low CSF A␤ 42 or positive amyloid PET. CSF biomarkers have shown similar diagnostic accuracy as both regional and composite PET measures [5] . CSF was recently demonstrated to reliably predict A␤ accumulation, where a CSF A␤ 42 concentration of 647 pg/ml or less identified a positive composite 18 F-Flut PET measure with high sensitivity and specificity [4] . However, regional differences in this aspect have not been investigated. In the current study, we find that regions known to harbor amyloid plaques in AD show abnormal 18 F-Flut retention at different CSF A␤ 42 concentrations (the inferior parietal lobe and posterior cingulate and precuneus present with abnormal 18 F-Flut SUVr at the highest concentrations, followed by the prefrontal cortex). There were strong negative correlations between CSF A␤ 42 and 18 FFlut SUVr in these regions, in line with previous findings [4] , and our analyses yielded sensitivity and specificity around 90% for all investigated regions and CSF cut-offs (Fig. 3) . The current findings are supported by the early involvement of these regions in the disease course [41] and local predilection for plaque deposition [45] .
This gives additional valuable information for CSF as a clinical tool, also considering the 18 F-Flut manufacturer's guidelines stating that a positive 18 F-Flut PET scan requires abnormal amyloid retention in at least one region [42] . This highlights the need for standardization of CSF biomarker analyses to define the optimal threshold for abnormal values. There is generally a large span in the CSF A␤ 42 cut-offs and cut-offs reported in the current study are slightly higher than what Palmqvist et al. found [4] . This may result from the known between-laboratory variability in CSF A␤ 42 analyses. There is a need for validation of these cut-offs to increase the diagnostic accuracy of CSF biomarkers, as CSF is an amenable clinical tool in many circumstances, and also to reduce the chances of false negatives.
Reduced cerebral glucose metabolism, as determined by 18 F-FDG PET, is a well-established feature of AD [46] . Previous studies combining amyloid PET and 18 F-FDG PET report conflicting results, some showing reduced glucose metabolism with increasing A␤ load [47, 48] , while others do not [49, 50] . When associations were observed, they seemed to be region-specific, involving mostly posterior brain regions. This is consistent with our findings of significant cortical regional correlations, with the strongest correlations observed in the precuneus, posterior cingulate and inferior parietal lobe, and additional prefrontal regions. These predilection sites mimic early changes in 18 F-Flut versus CSF (as described above). Significant associations were only found in 18 F-Flut(+) subjects, which may not be surprising due to the by design low cortical uptake in 18 F-Flut(-) subjects. However, it may also support previous hypotheses of toxic effects of A␤ on synaptic function in AD [47] , as increased fibrillar A␤ (as is detected with amyloid PET) has been associated with higher levels of toxic oligomers [51] .
We further investigated regional 18 F-Flut retention ( Table 2) . As expected, significantly higher cortical uptake was observed in 18 F-Flut(+) compared to 18 FFlut(-), using SUVr (Table 2 B) . PET images are prone to PVE [52] , primarily due to low spatial resolution, resulting in biased uptake measurements due to spill-over. For amyloid PET there may be an overestimation of cortical retention in healthy controls more than in AD due to relatively high WM retention, increasing the chances for false positives [53] . Therefore, correcting for PVE may improve statistical power [15] . This is illustrated by the higher cortical uptake in PVE uncorrected images compared to corrected images in 18 F-Flut(-) subjects, likely due to spill-over from WM. Similarly, in 18 F-Flut(+) subjects there may be a spill-over from GM to subcortical WM, illustrated by slightly larger ratios in PVE uncorrected compared to corrected images, causing a positive bias and overestimation of WM signal. This highlights the importance of such a correction, not only for accurate quantification of the cortical signal, but also for potential WM analyses.
SUV was used to investigate the validity of typical reference regions, for further analyses of WM (Table 2A) . This was done because group differences in reference regions may potentially impact SUVr, especially in regions with more subtle differences in 18 F-Flut uptake, e.g., WM. Higher SUV in 18 FFlut(+) was also observed in subcortical WM, with significant difference in WMHs, with and without PVE correction. Analyses with and without PVE correction were performed to investigate the potential impact of such correction also in WM analyses, as it is shown to increase the accuracy of analyses [15] . The high WM retention reported with 18 F-Flut raises the possibility of 18 F-Flut being a marker for WM pathology, though the binding characteristics of 18 FFlut in WM remain to be determined. We investigated subcortical retention in 18 F-Flut(+) and 18 F-Flut(-) to further explore the possible relationship between amyloid and WM pathology as this may improve the understanding of associations between CVD and AD. Investigating 18 F-Flut retention in WMHs, we found significant group differences in WMH 18 F-Flut uptake when comparing SUVs (i.e., prior to normalization) in 18 F-Flut(+) and 18 F-Flut(-), with the highest retention in 18 F-Flut(+). The differences were noticeably reduced when normalizing the uptake to a reference region (SUVr) and no longer significant. There is generally a slightly higher 18 F-Flut retention in subjects classified as 18 F-Flut(+), and a possible explanation for the reduction in differences may be the observed higher aberrant uptake across the entire brain in 18 F-Flut(+) subjects, including the typical reference regions cerebellum and brainstem in which specific binding is believed to be negligible. Furthermore, the findings must be interpreted with caution, as several factors are known to impact on SUV, and SUVr is considered the more precise and robust measure for amyloid PET.
High WM retention has been reported for several 18 F-PET ligands [10, 54, 55] . The WM binding of 18 F-Flut was recently investigated using spectral analysis and the authors concluded that WM binding was nonspecific, i.e., not related to amyloid binding [13] . This is in line with what has previously been reported with 18 F-Florbetaben using kinetic modelbased analyses [55] . This is supported by the current associations observed between 18 F-Flut and 18 F-FDG uptake in WMHs, as well as the lack of correlations between the 18 F-Flut uptake in WMHs and cortex in the current study. Accumulating evidence links CVD and AD [19] , and we have previously demonstrated impaired WMH microstructural integrity in A␤ positive subjects using diffusion tensor imaging [17] . Furthermore, we recently found reduced glucose metabolism in WMHs in the presence of amyloid dysmetabolism [16] . Increased fibrillar A␤ has been associated with higher levels of A␤ oligomers, suggested to be more neurotoxic and promote neurodegeneration [56] . Hence, the current findings of negative associations between the 18 F-FDG uptake in WMHs and cortical 18 F-Flut retention support our previous findings [16] , connecting increasing A␤ pathology to glucose hypometabolism in WMHs.
Tracer tissue extraction and clearance is related to cerebral blood flow (CBF), and CBF decreases during AD progression [22] . WMHs are often considered to result from hypoperfusion [57] , and previous studies using 11 C-PiB found reduced retention in WMHs compared to NAWM [25] [26] [27] . This has in addition been reported with another 18 F-PET ligand, 18 F-Florbetaben [58] , and we observed the same with 18 F-Flut in the current study. Hence one might expect lower 18 F-Flut uptake in WMHs in 18 FFlut(+). However, SUVr do not distinguish between the contributions of CBF and clearance, and clearance also depends on the capillary integrity, known to be reduced in AD [22] . In CAA type 1, as opposed to CAA type 2 (involving larger vessels), the capillaries are affected, reflected by A␤ deposition in the outer basement membrane [24] . Similar to A␤ plaques, these vascular changes present with surrounding microglia activation and inflammatory responses [59] . The vascular bed in AD further presents with several alterations. The microvascular distortion and capillary dysfunction affects the neurovascular unit, thereby affecting the blood-brain barrier function [60] causing impaired clearance of soluble substances [22, 23] . Given little or absent specific 18 F-Flut amyloid binding in WM, one possible explanation for the higher 18 F-Flut retention observed in WMHs in 18 F-Flut(+) subjects might be vascular damage present in AD impairing tracer clearance. The lack of difference observed in NAWM raises the possibility that these alterations are confined to WMHs. For other 18 F-ligands, white matter retention has also been hypothesized to result from reduced WM blood perfusion compared to the cortex and thus slower clearance [61] . However, due to the aberrant uptake observed 18 F-Flut (+), we cannot conclude that 18 F-Flut is a suitable marker for WM pathology and the current findings must be interpreted with caution. Replications in larger cohorts are warranted for further assessment of the use of 18 F-Flut in WM pathology.
The cross-sectional study design may be a limitation when considering regional comparisons of cortical 18 F-Flut retention and CSF A␤ 42 in patients destined to develop dementia due to AD, and longitudinal studies should be conducted for further evaluations of the regional A␤ depositions related to CSF A␤ 42 cut-offs.
In conclusion, although the study design and the relatively small sample size are limitations and replications in larger cohorts are warranted, this study gives further evidence for CSF A␤ 42 as a clinical tool to predict regional cortical A␤ deposition. In addition, our findings support previous hypotheses of toxic effects of A␤ on synaptic function based on the strong correlations observed between cortical 18 F-Flut and 18 F-FDG uptake. Furthermore, we replicate our previous findings [16] linking amyloid dysmetabolism to glucose hypometabolism in WMHs. We also demonstrate generally higher 18 F-Flut retention across the brain in subjects classified as 18 Authors' disclosures available online (https:// www.j-alz.com/manuscript-disclosures/17-0582r2).
